BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 119 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1 | -98.6% | 304 | -97.2% | 0.00% | – |
Q2 2023 | $73 | -64.0% | 10,951 | +0.6% | 0.00% | – |
Q1 2023 | $203 | -18.5% | 10,885 | -5.9% | 0.00% | – |
Q4 2022 | $249 | -99.8% | 11,571 | -0.1% | 0.00% | – |
Q3 2022 | $137,000 | -9.9% | 11,582 | +0.5% | 0.00% | – |
Q2 2022 | $152,000 | -36.9% | 11,525 | -0.2% | 0.00% | – |
Q1 2022 | $241,000 | +2.6% | 11,549 | -0.2% | 0.00% | – |
Q4 2021 | $235,000 | -33.0% | 11,574 | +0.2% | 0.00% | – |
Q3 2021 | $351,000 | -21.1% | 11,551 | -24.6% | 0.00% | – |
Q2 2021 | $445,000 | -53.3% | 15,310 | -30.6% | 0.00% | -100.0% |
Q1 2021 | $953,000 | +73.3% | 22,070 | +85.5% | 0.00% | 0.0% |
Q4 2020 | $550,000 | +30.6% | 11,900 | +22.7% | 0.00% | 0.0% |
Q3 2020 | $421,000 | -18.1% | 9,700 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $514,000 | +264.5% | 9,700 | +54.0% | 0.00% | – |
Q1 2020 | $141,000 | +5.2% | 6,300 | -31.5% | 0.00% | – |
Q4 2019 | $134,000 | +106.2% | 9,200 | 0.0% | 0.00% | – |
Q3 2019 | $65,000 | -35.6% | 9,200 | 0.0% | 0.00% | – |
Q2 2019 | $101,000 | – | 9,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |